Working… Menu

Cetuximab, Capecitabine, Oxaliplatin and Bevacizumab in Advanced Colorectal Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00208546
Recruitment Status : Completed
First Posted : September 21, 2005
Last Update Posted : February 2, 2012
Koningin Wilhelmina Fonds
Roche Pharma AG
Information provided by (Responsible Party):
Dutch Colorectal Cancer Group

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : July 2009
Actual Study Completion Date : December 2009
Publications of Results:
Publications automatically indexed to this study by Identifier (NCT Number):